From: Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
 | 3 F-PCC | 4 F-PCC | ||||||
---|---|---|---|---|---|---|---|---|
Bebulin® (Baxter) | Preconativ (Kabi) | Proplex-Tb (Baxter) | Beriplex P/N® (CSL Behring) | Kaskadil® (LFFBc) | Octaplex® (Octapharma) | Cofact® (Sanquin) | PPSB-HT Nichiyaku (Nihon) | |
Factor II | 24–38 | 50 | 50 | 31 | 37 | 10–40 | 14–35 | 20 |
Factor VII | <5 | NA | 400 | 16 | 10 | 10–40 | 7–20 | 20 |
Factor IX | 24–38 | 60 | 100 | 29 | 25 | 20–31 | 25 | 20 |
Factor X | 24–38 | 50 | 50 | 41 | 40 | 10–40 | 14–35 | 20 |
Protein C |  |  |  | 35 |  | 10–40 |  | 15 |
Protein S |  |  |  | 25 |  | 10–40 |  |  |
Protein Z | Â | Â | Â | 36 | Â | Â | Â | Â |
Antithrombin III | Â | Â | Â | 0.6 | Â | Â | <0.6 | Â |
Heparin | <0.15 IU/IU FIX |  | <1.5 | 0.5 | 5 | 4–15 | None |  |